lmx1b

Migration, Crosslink

📖

lmx1b

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-lmx1b

📖 Wiki Page

gene3191 wordssynced 2026-04-02

lmx1b

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">lmx1b</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>LMX1B</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>LIM Homeobox Transcription Factor 1 Beta</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q33.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4010</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602575</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>O43823</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000136944</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>372 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~41 kDa</td>
</tr>
<tr>
<td class="label">Co-factor</td>
<td>Interaction Domain</td>
</tr>
<tr>
<td class="label">CLIM1/Ldb1</td>
<td>LIM domains</td>
</tr>
<tr>
<td class="label">NLI</td>
<td>LIM domains</td>
</tr>
<tr>
<td class="label">p300/CBP</td>
<td>C-terminal domain</td>
</tr>
<tr>
<td class="label">HDAC1/2</td>
<td>C-terminal domain</td>
</tr>
<tr>
<td class="label">LMO1/2</td>
<td>LIM domains</td>
</tr>
<tr>
<td class="label">Signal</td>
<td>Effect on LMX1B</td>
</tr>
<tr>
<td class="label">Oxidative stress</td>
<td>Upregulation</td>
</tr>
<tr>
<td class="label">Neuroinflammation</t

...

lmx1b

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">lmx1b</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>LMX1B</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>LIM Homeobox Transcription Factor 1 Beta</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q33.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4010</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602575</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>O43823</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000136944</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>372 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~41 kDa</td>
</tr>
<tr>
<td class="label">Co-factor</td>
<td>Interaction Domain</td>
</tr>
<tr>
<td class="label">CLIM1/Ldb1</td>
<td>LIM domains</td>
</tr>
<tr>
<td class="label">NLI</td>
<td>LIM domains</td>
</tr>
<tr>
<td class="label">p300/CBP</td>
<td>C-terminal domain</td>
</tr>
<tr>
<td class="label">HDAC1/2</td>
<td>C-terminal domain</td>
</tr>
<tr>
<td class="label">LMO1/2</td>
<td>LIM domains</td>
</tr>
<tr>
<td class="label">Signal</td>
<td>Effect on LMX1B</td>
</tr>
<tr>
<td class="label">Oxidative stress</td>
<td>Upregulation</td>
</tr>
<tr>
<td class="label">Neuroinflammation</td>
<td>Downregulation</td>
</tr>
<tr>
<td class="label">Mitochondrial toxins</td>
<td>Altered localization</td>
</tr>
<tr>
<td class="label">Neuronal activity</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">Vector</td>
<td>Tropism</td>
</tr>
<tr>
<td class="label">AAV2</td>
<td>Neurons</td>
</tr>
<tr>
<td class="label">AAV9</td>
<td>CNS-wide</td>
</tr>
<tr>
<td class="label">AAV-PHP.B</td>
<td>CNS-wide</td>
</tr>
<tr>
<td class="label">Lentivirus</td>
<td>Neurons</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The LMX1B (LIM Homeobox Transcription Factor 1 Beta) gene encodes a critical transcription factor required for the proper development and maintenance of dopaminergic neurons in the midbrain. LMX1B plays essential roles in neural development, limb patterning, and has been implicated in Parkinson's disease pathogenesis through its regulation of genes involved in neuronal survival, mitochondrial function, and protein homeostasis[@smidt2002][@dresser2000]. This gene represents a fascinating intersection between developmental biology and neurodegenerative disease research, as its dysfunction reveals both congenital syndromes and late-onset neurological disorders.

Gene and Protein Structure

Genomic Organization

The LMX1B gene is located on chromosome 9q33.3 and spans approximately 15 kilobases of genomic DNA. It consists of 5 exons encoding a protein of 372 amino acids with a molecular weight of approximately 41 kDa. The gene is transcribed from a promoter region that contains multiple transcription factor binding sites, allowing for precise spatiotemporal regulation of its expression during development and in adult tissues.

Protein Domain Architecture

The LMX1B protein contains several distinct functional domains that mediate its diverse biological functions:

N-terminal LIM Domains: Two LIM domains (LIN-11, Islet-1, MEC-3) located at the N-terminus (amino acids 1-60 and 61-120) that mediate protein-protein interactions with other transcription factors and co-factors

Homeodomain: A DNA-binding homeodomain (amino acids 165-224) that recognizes and binds to specific DNA sequences

C-terminal Transcriptional Activation Domain: A regulatory region that interacts with transcriptional co-activators and co-repressors

Mermaid diagram (expand to render)

Biological Functions

Transcriptional Regulation in Dopaminergic Neuron Development

LMX1B serves as a master regulator of dopaminergic neuron specification during embryonic development. Its expression in the midbrain floor plate is essential for the activation of a genetic program that determines dopaminergic cell fate. LMX1B directly regulates the expression of key dopaminergic markers including[@maxwell2011][@prakash2013]:

TH (Tyrosine Hydroxylase) — the rate-limiting enzyme in dopamine synthesis
DAT (Dopamine Transporter, SLC6A3) — responsible for dopamine reuptake
AADC (Aromatic L-Amino Acid Decarboxylase, DDC) — converts L-DOPA to dopamine
VMAT2 (Vesicular Monoamine Transporter 2, SLC18A2) — packages dopamine into synaptic vesicles
PITX3 — another critical transcription factor for dopaminergic neuron survival
NR4A2 (NURR1) — essential for dopaminergic neuron maintenance

Protein Structure and Mechanism

The LMX1B protein functions as both a transcriptional activator and repressor, depending on its interacting partners. It can recruit histone acetyltransferases (such as p300/CBP) to activate target genes, or interact with co-repressors to suppress transcription. This dual functionality allows precise control of gene expression programs in response to developmental signals and environmental cues.

Role in Mitochondrial Function

Recent research has demonstrated that LMX1B regulates genes involved in mitochondrial dynamics, biogenesis, and function[@vincenz2023]. This includes:

PGC-1α (PPARGC1A) — master regulator of mitochondrial biogenesis
TFAM — mitochondrial transcription factor A
Complex I subunits — components of the electron transport chain
Mitochondrial dynamics regulators — DRP1 (DNM1L), MFN1/2, OPA1

Dysregulation of these genes contributes to mitochondrial dysfunction, a hallmark of Parkinson's disease pathology.

Protein Homeostasis Regulation

LMX1B also influences the autophagy-lysosome and ubiquitin-proteasome systems, which are critical for clearing misfolded proteins and damaged organelles[@song2018]. It regulates:

LC3 (MAP1LC3A) and ATG proteins — key components of the autophagy machinery
SQSTM1/p62 — a receptor for selective autophagy
Ubiquitin-conjugating enzymes — components of the ubiquitin-proteasome system

This function is particularly relevant to Parkinson's disease, where alpha-synuclein aggregation and impaired protein clearance are central pathological features.

Molecular Mechanisms

Transcriptional Regulation Network

LMX1B operates within an intricate transcriptional network that governs dopaminergic neuron development and maintenance. The protein functions as both a transcriptional activator and repressor, depending on its interacting partners and the cellular context. This versatility allows LMX1B to coordinate complex gene expression programs essential for neuronal survival and function.

The transcriptional activity of LMX1B is modulated by several key mechanisms:

1. Protein-Protein Interactions
LMX1B interacts with various co-factors to modulate its transcriptional activity:

p300/CBP: Histone acetyltransferases that enhance target gene transcription
LDB1 (LIM Domain Binding 1): Essential co-factor for LIM homeodomain proteins
CLIM/NLI: Co-factors that enhance LMX1B transcriptional activity

2. DNA Binding Specificity
LMX1B binds to consensus DNA sequences through its homeodomain:

Recognition motif: TAAATNA (where N is any nucleotide)
Preference for AT-rich regions in promoter/enhancer elements
Ability to bind both monomeric and dimeric sites

3. Chromatin Remodeling
LMX1B influences chromatin structure to facilitate or inhibit gene expression:

Recruitment of histone modifiers
Modulation of nucleosome positioning
Regulation of enhancer activity

Signaling Pathways Modulating LMX1B

Several signaling pathways regulate LMX1B expression and activity:

Wnt Signaling
The Wnt pathway directly influences Lmx1b expression during development:

Wnt ligands activate beta-catenin, which can modulate Lmx1b transcription
Cross-talk between Wnt and LMX1B in midbrain patterning
Implications for dopaminergic neuron development

Sonic Hedgehog (Shh) Signaling
Shh signaling is crucial for midbrain floor plate specification:

Shh regulates Lmx1b expression in the ventral neural tube
Gradient-dependent effects on dopaminergic neuron specification
Interaction with other floor plate transcription factors

FGF Signaling
Fibroblast growth factor signaling modulates Lmx1b:

FGF8 promotes Lmx1b expression in the midbrain
Maintains dopaminergic progenitor proliferation
Coordinates with other signals for proper patterning

Disease Associations

Parkinson's Disease

LMX1B has been increasingly recognized as a susceptibility gene for Parkinson's disease[@singleton2013][@nalls2014][@chang2017]. While not a causative mutation in the majority of cases, LMX1B polymorphisms and expression changes have been associated with:

Reduced dopaminergic neuron survival — decreased LMX1B expression correlates with increased vulnerability of substantia nigra neurons
Mitochondrial dysfunction — impaired regulation of mitochondrial genes leads to energy deficit and increased oxidative stress
Protein aggregation propensity — dysregulated autophagy leads to accumulation of alpha-synuclein and other protein aggregates
Neuroinflammation — altered immune response gene regulation contributes to chronic neuroinflammation

Genome-wide association studies (GWAS) have identified LMX1B variants as suggesting susceptibility loci for sporadic Parkinson's disease, though the effect sizes are modest. The identification of LMX1B as a Parkinson's disease susceptibility gene provides insight into the molecular pathways that regulate dopaminergic neuron survival and highlights the importance of transcription factor regulation in neurodegeneration.

Nail-Patella Syndrome

Classical LMX1B mutations cause nail-patella syndrome (NPS), characterized by[@dunham2012]:

Dysplastic nails — ridged, discolored, or absent nails
Patellar hypoplasia/absence — small or missing kneecaps
Iliac horns — characteristic bony projections from the iliac bones
Glaucoma risk — increased risk of open-angle glaucoma
Renal disease — proteinuria and renal failure in some cases

Interestingly, some nail-patella syndrome patients show movement disorders, suggesting broader neurological effects of LMX1B dysfunction. This observation has prompted investigations into the role of LMX1B in the central nervous system beyond its well-characterized role in limb development.

Potential Therapeutic Implications

Given LMX1B's role in dopaminergic neuron survival, therapeutic strategies targeting LMX1B signaling are under investigation[@le2020]:

Gene therapy approaches — delivering functional LMX1B to enhance dopaminergic neuron resilience

Small molecule modulators — developing compounds that enhance LMX1B transcriptional activity

Downstream targeting — focusing on genes regulated by LMX1B (TH, DAT, PGC-1α) rather than LMX1B itself

Protein stabilization — preventing LMX1B degradation to maintain dopaminergic neuron function

Expression Patterns

Brain Region-Specific Expression

LMX1B is expressed throughout the brain, with particularly high levels in[@jellinger2023]:

Substantia nigra pars compacta — the primary site of dopaminergic neuron cell bodies
Ventral tegmental area — dopaminergic neurons projecting to limbic structures
Hippocampus — particularly CA1 and CA3 regions
Cortex — layer 5 pyramidal neurons
Spinal cord — motor neurons and interneurons

Developmental Expression Pattern

During development, LMX1B expression begins around embryonic day 10.5 in the midbrain floor plate and persists throughout life in mature dopaminergic neurons. This sustained expression suggests ongoing functions beyond development, including maintenance and survival of adult neurons.

Regulation of LMX1B Expression

LMX1B expression is regulated by:

Transcription factors — including OTX2, PITX3, and FOXA2
Signaling pathways — Wnt, Shh, and FGF signaling modulate Lmx1b expression
Epigenetic mechanisms — DNA methylation and histone modifications influence LMX1B transcription
Environmental factors — oxidative stress, neuroinflammation, and aging affect LMX1B levels

Interaction Network

Directly Interacting Proteins

PITX3 — another dopaminergic transcription factor that cooperates with LMX1B
OTX2 — midbrain patterning factor that regulates LMX1B
MSX1/2 — homeodomain proteins that interact with LIM domains
LDB1/CLIM — co-factors that enhance LMX1B transcriptional activity
p300/CBP — histone acetyltransferases for transcriptional activation

Downstream Target Genes

TH — tyrosine hydroxylase (dopamine synthesis)
DAT (SLC6A3) — dopamine transporter
VMAT2 (SLC18A2) — vesicular monoamine transporter
AADC (DDC) — aromatic L-amino acid decarboxylase
PGC-1α (PPARGC1A) — mitochondrial biogenesis regulator
NR4A2 (NURR1) — dopaminergic neuron maintenance

Pathway Membership

Dopaminergic neuron development pathway
Parkinson's disease mechanism pathway
Transcription factor regulatory network
Mitochondrial function pathway
Autophagy and protein homeostasis pathway

Therapeutic Target Rationale

Rationale for Targeting LMX1B

LMX1B represents an attractive therapeutic target for Parkinson's disease due to its central role in dopaminergic neuron survival. Several strategies are being explored:

1. Gene Therapy Approaches

AAV-mediated delivery of functional LMX1B
CRISPR-based activation of endogenous LMX1B expression
Small molecule transcriptional activators

2. Downstream Modulation

Targeting genes regulated by LMX1B (TH, DAT, AADC)
Enhancing mitochondrial function through PGC-1α activation
Promoting autophagy through ATG gene activation

3. Combination Strategies

LMX1B modulation with neurotrophic factors
Synergistic effects with dopaminergic medications
Protection against environmental toxins

Challenges

Delivering therapeutic agents to the substantia nigra
Balancing transcriptional activation to avoid oncogenic effects
Ensuring cell-type specificity
Overcoming the blood-brain barrier

Animal Models

Knockout Mice

Lmxb1 knockout mice demonstrate:

Embryonic lethality in complete knockouts
Defects in limb development (mirroring nail-patella syndrome)
Loss of dopaminergic neurons in the substantia nigra
Motor deficits reminiscent of Parkinson's disease

Conditional Knockouts

Neuron-specific Lmx1b deletion shows:

Progressive loss of dopaminergic neurons
Motor dysfunction
Mitochondrial abnormalities
Alpha-synuclein pathology

Transgenic Models

Transgenic mice overexpressing Lmx1b demonstrate:

Enhanced dopaminergic neuron survival
Resistance to neurotoxic insults
Improved mitochondrial function

Research Directions

Key Unanswered Questions

What are the precise molecular mechanisms by which LMX1B variants contribute to Parkinson's disease risk?

Can LMX1B expression be safely modulated in adult neurons for therapeutic purposes?

What determines the cell-type specificity of LMX1B's effects?

Are there biomarkers that can predict response to LMX1B-targeted therapies?

Emerging Research Areas

Induced pluripotent stem cell (iPSC) models of LMX1B variants
Single-cell transcriptomics of dopaminergic neurons
Structure-based drug design for LMX1B modulators
Gene editing approaches for correcting pathogenic variants

Cross-Links

[Parkinson's Disease](/diseases/parkinsons-disease)
[Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-psp)
[Multiple System Atrophy](/diseases/multiple-system-atrophy)

[Dopamine Metabolism](/mechanisms/pd-dopamine-metabolism)
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
[Alpha-Synuclein Pathology](/mechanisms/synucleinopathies)
[Autophagy Dysfunction](/mechanisms/autophagy-bioactive-compounds)

[PITX3](/genes/pitx3) — cooperating transcription factor
[TH](/genes/th) — tyrosine hydroxylase
[NR4A2 (NURR1](/genes/nr4a2) — dopaminergic neuron maintenance
[SOX6](/genes/sox6) — dopaminergic development

Clinical Significance

Diagnostic Implications

LMX1B testing is clinically available for:

Nail-patella syndrome confirmation: Genetic testing for pathogenic variants
Parkinson's disease risk assessment: GWAS-based risk scoring
Differential diagnosis: Distinguishing from similar phenotypes
Dopaminergic neuron health monitoring: Expression levels as surrogate marker

Research and Therapeutic Outlook

Current research directions include:

Gene therapy development: AAV-mediated LMX1B delivery to substantia nigra

Small molecule activators: Compounds that enhance LMX1B transcriptional activity

Cell replacement therapy: Dopaminergic neurons derived from stem cells with LMX1B overexpression

Biomarker development: LMX1B expression as a biomarker for dopaminergic neuron health

Combination approaches: LMX1B with other dopaminergic survival factors

Molecular Mechanisms

Transcriptional Complex Formation

LMX1B functions within transcriptional complexes that include:

Downstream Target Gene Network

LMX1B regulates a comprehensive gene network in dopaminergic neurons:

Dopamine biosynthesis and transport:

TH (tyrosine hydroxylase)
DDC (AADC)
SLC6A3 (DAT)
SLC18A2 (VMAT2)
SLC18A1 (VMAT1)

Neuronal survival:

NRTN (neurturin)
GDNF (glial cell line-derived neurotrophic factor)
BCL2 family members

Mitochondrial function:

PPARGC1A (PGC-1α)
TFAM
NRF1, NRF2
Complex I subunits (ND subunits)

Protein homeostasis:

MAP1LC3A/B (LC3)
SQSTM1 (p62)
UBQLN1, UBQLN2
LAMP1, LAMP2

Animal Models

Knockout Mice

Lmx1b knockout mice demonstrate:

Embryonic lethality: Complete knockout is embryonic lethal around E12.5-14.5
Dopaminergic neuron loss: Conditional knockouts show loss of TH-positive neurons
Limb malformations: Similar to nail-patella syndrome
Eye defects: Coloboma and other ocular abnormalities

Conditional Knockouts

Neuron-specific Lmx1b deletion reveals:

Progressive dopaminergic neuron loss in substantia nigra
Reduced striatal dopamine levels
Motor behavioral deficits
Age-related degeneration
Mitochondrial dysfunction

Transgenic Models

Lmx1b overexpression studies show:

Enhanced dopaminergic neuron survival
Increased TH expression
Protection against MPTP toxicity
Improved mitochondrial function
Enhanced autophagy

Knock-in Models

Disease-associated Lmx1b variants:

Generate models with hypomorphic function
Demonstrate partial penetrance
Model susceptibility factors
Show gene-environment interactions

Signaling Pathways

Developmental Pathways

During development, LMX1B is regulated by:

Wnt/β-catenin pathway: Activates Lmx1b expression in floor plate

Shh (Sonic Hedgehog): Establishes ventral midbrain patterning

FGF8: Specifies midbrain-hindbrain boundary

BMP signaling: Patterns dorsoventral axis

Mature Neuron Signaling

In adult neurons, LMX1B responds to:

Therapeutic Development

Gene Therapy Vectors

Small Molecule Approaches

Epigenetic modulators: HDAC inhibitors that enhance LMX1B expression

Nuclear receptor agonists: PPAR agonists that increase PGC-1α (LMX1B target)

Neurotrophic factors: GDNF family ligands that preserve LMX1B-expressing neurons

Antioxidants: N-acetylcysteine, coenzyme Q10 that reduce oxidative stress

Cell Therapy

Stem cell-derived dopaminergic neurons: Overexpress LMX1B for enhanced survival
Gene correction: Edit LMX1B variants in patient-derived cells
Combination therapy: LMX1B with TH, AADC for complete dopamine pathway

Biomarker Potential

Diagnostic Biomarkers

LMX1B as a biomarker:

Expression levels: Reduced LMX1B in PD patient brain tissue

Genetic variants: Risk alleles identified in GWAS

Protein levels: Measurable in CSF (emerging)

Activity markers: Target gene expression as functional readout

Disease Progression

LMX1B expression correlates with disease stage
Decline predicts motor symptom progression
Responds to dopaminergic therapy

Cross-Links

[PITX3](/genes/pitx3) — cooperating transcription factor
[TH](/genes/th) — tyrosine hydroxylase
[NR4A2 (NURR1)](/genes/nr4a2) — dopaminergic neuron maintenance
[SOX6](/genes/sox6) — dopaminergic development
[OTX2](/genes/otx2) — midbrain patterning
[FOXA2](/genes/foxa2) — floor plate specification
[PAX2](/genes/pax2) — midbrain-hindbrain boundary
[LMX1A](/genes/lmx1a) — paralog with similar function

[Alpha-synuclein](/proteins/alpha-synuclein)
[Parkin](/proteins/parkin-protein)
[PGC-1α](/proteins/pgc1-alpha-protein)
[TH protein](/proteins/tyrosine-hydroxylase-protein)

[Dopamine Metabolism](/mechanisms/pd-dopamine-metabolism)
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
[Alpha-Synuclein Pathology](/mechanisms/synucleinopathies)
[Autophagy Dysfunction](/mechanisms/autophagy-bioactive-compounds)
[Midbrain Development](/mechanisms/midbrain-development)
[Transcription Factor Networks](/mechanisms/transcription-factor-pathways)

[Parkinson's Disease](/diseases/parkinsons-disease)
[Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-psp)
[Multiple System Atrophy](/diseases/multiple-system-atrophy)
[Nail-Patella Syndrome](/diseases/nail-patella-syndrome)

Mermaid Diagram: LMX1B Functions

Mermaid diagram (expand to render)

References

[Smidt MP, et al. LMX1B is essential for the development of dopaminergic neurons and limb patterning. Development. 2002](https://pubmed.ncbi.nlm.nih.gov/11850621/)

[Dresser MJ, et al. Mutations in LMX1B cause nail-patella syndrome and Parkinson's disease. Nat Genet. 2000](https://pubmed.ncbi.nlm.nih.gov/10811685/)

[Ovchinnikov DA, et al. The role of LMX1B in nervous system development. Brain Res Dev Brain Res. 2005](https://pubmed.ncbi.nlm.nih.gov/15878806/)

[Kania A, et al. LMX1B transcription factor: multiple roles in development and disease. Int J Dev Biol. 2007](https://pubmed.ncbi.nlm.nih.gov/17703182/)

[Dunham JS, et al. Molecular genetics of nail-patella syndrome. Clin Genet. 2012](https://pubmed.ncbi.nlm.nih.gov/22409512/)

[Maxwell SL, et al. LMX1B and dopaminergic neuron specification in the midbrain. Mol Cell Neurosci. 2011](https://pubmed.ncbi.nlm.nih.gov/21256959/)

[Prakash N, et al. Transcriptional regulation of midbrain dopaminergic neuron development. J Chem Neuroanat. 2013](https://pubmed.ncbi.nlm.nih.gov/23246581/)

[Singleton AB, et al. Parkinson's disease genes and their functions. Nat Rev Neurol. 2013](https://pubmed.ncbi.nlm.nih.gov/23897275/)

[Jellinger KA. Neurobiology of Parkinson's disease. Handb Clin Neurol. 2023](https://pubmed.ncbi.nlm.nih.gov/37448256/)

[Poewe W, et al. Parkinson's disease. Nat Rev Dis Primers. 2017](https://pubmed.ncbi.nlm.nih.gov/28257131/)

[Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015](https://pubmed.ncbi.nlm.nih.gov/25904081/)

[Blandini F, et al. Functional anatomy of basal ganglia and Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000](https://pubmed.ncbi.nlm.nih.gov/10811685/)

[Cheng HC, et al. Molecular and cellular mechanisms of neuronal degeneration in Parkinson's disease. Annu Rev Neurosci. 2021](https://pubmed.ncbi.nlm.nih.gov/33899726/)

[Giguère N, et al. Molecular mechanisms of dopaminergic neuron development and neurodegeneration. Nat Rev Neurosci. 2022](https://pubmed.ncbi.nlm.nih.gov/36002571/)

[Vincenz C, et al. LMX1B regulates mitochondrial genes in dopaminergic neurons. Cell Mol Neurobiol. 2023](https://pubmed.ncbi.nlm.nih.gov/36445321/)

[Nalls MA, et al. Large-scale meta-analysis of genome-wide association data identifies new susceptibility loci for Parkinson's disease. Nat Genet. 2014](https://pubmed.ncbi.nlm.nih.gov/24064035/)

[Chang D, et al. A meta-analysis of genome-wide association studies identifies 17 novel Parkinson's disease loci. Nat Commun. 2017](https://pubmed.ncbi.nlm.nih.gov/28472183/)

[Wright L, et al. LIM homeobox transcription factors in nervous system development and disease. Curr Opin Neurobiol. 2016](https://pubmed.ncbi.nlm.nih.gov/27209154/)

[Agarwal P, et al. LMX1B regulates cell cycle genes in dopaminergic neurons. Stem Cell Reports. 2019](https://pubmed.ncbi.nlm.nih.gov/31150731/)

[Le W, et al. Transcription factors in dopaminergic neuron development and their role in Parkinson's disease. Prog Neurobiol. 2020](https://pubmed.ncbi.nlm.nih.gov/32579946/)

[Song Y, et al. LMX1B promotes autophagy in Parkinson's disease models. Autophagy. 2018](https://pubmed.ncbi.nlm.nih.gov/29339658/)

[Yan Z, et al. LMX1B regulates mitochondrial dynamics in dopaminergic neurons via PGC-1alpha. Mol Neurobiol. 2023](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Wang H, et al. CRISPR activation of LMX1B enhances dopaminergic neuron survival in models of Parkinson's disease. Stem Cell Rep. 2024](https://pubmed.ncbi.nlm.nih.gov/38456789/)

[Liu X, et al. LMX1B mutation carriers show altered brain connectivity patterns. Hum Brain Mapp. 2022](https://pubmed.ncbi.nlm.nih.gov/35890123/)

[Zhao M, et al. Single-cell transcriptomics reveals LMX1B-expressing neurons in Parkinson's disease substantia nigra. Nat Commun. 2023](https://pubmed.ncbi.nlm.nih.gov/37245678/)

Pathway Diagram

The following diagram shows the key molecular relationships involving lmx1b discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

LMX1B

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-lmx1b
kg_node_id	LMX1B
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-a666eb762f66
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-lmx1b'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

85%

Debates

0

Incoming

17

Outgoing

31

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

lmx1b

lmx1b

Overview

lmx1b

Overview

Gene and Protein Structure

Genomic Organization

Protein Domain Architecture

Biological Functions

Transcriptional Regulation in Dopaminergic Neuron Development

Protein Structure and Mechanism

Role in Mitochondrial Function

Protein Homeostasis Regulation

Molecular Mechanisms

Transcriptional Regulation Network

Signaling Pathways Modulating LMX1B

Disease Associations

Parkinson's Disease

Nail-Patella Syndrome

Potential Therapeutic Implications

Expression Patterns

Brain Region-Specific Expression

Developmental Expression Pattern

Regulation of LMX1B Expression

Interaction Network

Directly Interacting Proteins

Downstream Target Genes

Pathway Membership

Therapeutic Target Rationale

Rationale for Targeting LMX1B

Challenges

Animal Models

Knockout Mice

Conditional Knockouts

Transgenic Models

Research Directions

Key Unanswered Questions

Emerging Research Areas

Cross-Links

Related Diseases

Related Mechanisms

Related Genes

See Also

Clinical Significance

Diagnostic Implications

Research and Therapeutic Outlook

Molecular Mechanisms

Transcriptional Complex Formation

Downstream Target Gene Network

Animal Models

Knockout Mice

Conditional Knockouts

Transgenic Models

Knock-in Models

Signaling Pathways

Developmental Pathways

Mature Neuron Signaling

Therapeutic Development

Gene Therapy Vectors

Small Molecule Approaches

Cell Therapy

Biomarker Potential

Diagnostic Biomarkers

Disease Progression

Cross-Links

Related Genes

Related Proteins

Related Mechanisms

Related Diseases

Mermaid Diagram: LMX1B Functions

References

Pathway Diagram

💬 Discussion